NAV
120.71(1.07%)Fund Size (CR)
₹8,352.16Expense Ratio
1.8Scheme Type
Active FundValue Research
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹100Minimum Withdrawal
₹100Exit Load
1%Return Since Launch
20.46%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Sailesh Raj Bhan
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 20 June 2025 | 10223.56 | 2.24% | - | 2.48% | 578/876 |
| 1 Month | 27 May 2025 | 10267.59 | 2.68% | - | 3.58% | 641/872 |
| 3 Month | 27 March 2025 | 10746.43 | 7.46% | - | 10.45% | 748/860 |
| 6 Month | 27 December 2024 | 9957.48 | -0.43% | - | 2.55% | 565/820 |
| 1 Year | 27 June 2024 | 11699.00 | 16.99% | 16.99% | 6.01% | 68/693 |
| 3 Year | 27 June 2022 | 19815.19 | 98.15% | 25.58% | 24.47% | 189/480 |
| 5 Year | 26 June 2020 | 27109.20 | 171.09% | 22.05% | 25.18% | 275/390 |
| Since Inception | 5 June 2004 | 505854.50 | 4958.54% | 20.46% | 14.77% | 216/876 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 1 July 2024 | 1,20,000 | 498052.80 | 315.04% | 315.04% |
| 3 Year | 1 July 2022 | 3,60,000 | 1873007.18 | 420.28% | 73.28% |
| 5 Year | 1 July 2020 | 6,00,000 | 3427983.47 | 471.33% | 41.70% |
| 10 Year | 1 July 2015 | 12,00,000 | 8645640.33 | 620.47% | 21.83% |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.32%
Standard Deviation
0.73%
Beta
1.09%
Sharpe Ratio
0.09%
Treynor's Ratio
10.86%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 12.57% | 6256349 | 1049.57 | Equity | Pharmaceuticals |
| Divi's Lab. | 9.49% | 1198808 | 792.65 | Equity | Pharmaceuticals |
| Lupin | 5.82% | 2483991 | 486.29 | Equity | Pharmaceuticals |
| Cipla | 5.62% | 3200000 | 469.02 | Equity | Pharmaceuticals |
| Dr Reddy's Labs | 5.49% | 3662170 | 458.21 | Equity | Pharmaceuticals |
| Apollo Hospitals | 5.34% | 648795 | 446.40 | Equity | Healthcare |
| Medplus Health | 4.20% | 3627277 | 350.54 | Equity | Retail |
| Glaxosmi. Pharma | 3.73% | 943731 | 311.30 | Equity | Pharmaceuticals |
| Vijaya Diagnost. | 3.24% | 2831564 | 270.78 | Equity | Healthcare |
| Narayana Hrudaya | 2.94% | 1406946 | 245.36 | Equity | Healthcare |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| WhiteOak Capital Pharma and Healthcare Fund-Dir (G) | 331.66 | 3.98% | 5.97% | 0.30% | 30.46% | - | |
| HDFC Pharma and Healthcare Fund - Direct (G) | 1704.87 | 2.74% | 4.81% | -0.29% | 29.53% | - | |
| HDFC Pharma and Healthcare Fund - Direct (IDCW) | 1704.87 | 2.74% | 4.81% | -0.29% | 29.53% | - | |
| Aditya Birla SL International Equity Fund - Direct (IDCW) | 206.77 | 3.04% | 8.83% | 17.13% | 25.95% | 14.13% | |
| Aditya Birla SL International Equity Fund - Direct (G) | 206.77 | 3.04% | 8.83% | 17.13% | 25.95% | 14.13% |
List of Schemes under Nippon India Mutual Fund
News
Nippon India Mutual Fund announces change in scheme name
Nippon India Mutual Fund has announced change in scheme name under the following schemes, With effect from 30 June 2025.Change in the name of the Scheme:
Existing Scheme Name Revised Scheme Name Nippon India Focused Equity Fund Nippon India Focused Fund Nippon India Growth Fund Nippon India Growth Mid Cap Fund Nippon India Vision Fund Nippon India Vision Large & Mid Cap Fund Nippon India Equity Hybrid Fund (Existing Number of SegregatedPortfolios - 2) Nippon India Aggressive Hybrid Fund (Existing Number of Segregated Portfolios - 2) Nippon India Hybrid Bond Fund (Existing Number of Segregated Portfolios - 1) Nippon India Conservative Hybrid Fund (Existing Number of Segregated Portfolios - 1) Nippon India Banking & PSU Debt Fund Nippon India Banking and PSU Fund Nippon India Floating Rate Fund Nippon India Floater Fund Nippon India Gilt Securities Fund Nippon India Gilt Fund Nippon India Income Fund Nippon India Medium to Long Duration Fund Nippon India Nivesh Lakshya Fund Nippon India Nivesh Lakshya Long Duration Fund Nippon India Short Term Fund Nippon India Short Duration Fund Nippon India Strategic Debt Fund (Existing Number of Segregated Portfolios - 1) Nippon India Medium Duration Fund (Existing Number of Segregated Portfolios - 1) Nippon India Fixed Horizon Fund - XLI - Series 8 Nippon India Fixed Maturity Plan - XLI - Series 8 Nippon India Fixed Horizon Fund - XLIII - Series 1 Nippon India Fixed Maturity Plan - XLIII - Series 1 Nippon India Fixed Horizon Fund - XLIII - Series 5 Nippon India Fixed Maturity Plan - XLIII - Series 5 Nippon India Fixed Horizon Fund - XLIV - Series 1 Nippon India Fixed Maturity Plan - XLIV - Series 1 Nippon India Fixed Horizon Fund - XLIV - Series 4 Nippon India Fixed Maturity Plan - XLIV - Series 4 Nippon India Fixed Horizon Fund - XLV - Series 4 Nippon India Fixed Maturity Plan - XLV - Series 4 Nippon India Fixed Horizon Fund - XLV - Series 5 Nippon India Fixed Maturity Plan - XLV - Series 5 Powered by Capital Market - Live News
Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)
Nippon India Mutual Fund has announced 13 June 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) on the face value of Rs 10 per unit under the regular plan ' IDCW payout and direct plan ' IDCW payout of Nippon India Balanced Advantage Fund. The quantum of distribution will be Rs 0.2200 per unit under each plan / option as on the record date.Powered by Capital Market - Live News
Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)
Nippon India Mutual Fund has announced 14 May 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) on the face value of Rs 10 per unit under the regular plan ' IDCW payout and direct plan ' IDCW payout of Nippon India Balanced Advantage Fund. The quantum of distribution will be Rs 0.2200 per unit under each plan / option as on the record date.Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
10 May 2004
Total AUM (Cr)
₹8352.16
Nippon India Pharma Fund (IDCW) is an Sectoral / Thematic-oriented fund from the renowned AMC, Nippon India Mutual Fund. Launched in 10 May 2004, this fund is managed by Sailesh Raj Bhan. With assets under management (AUM) worth ₹8,352.16 (Cr), as of 27 June 2025, Nippon India Pharma Fund (IDCW) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 20.46% since its launch.
The current NAV of Nippon India Pharma Fund (IDCW) is ₹120.71, as on 27 June 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in Nippon India Pharma Fund (IDCW) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units. The fund has generated 25.58% and 22.05% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.60% in Equity, 1.52% in Debt and -0.12% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 77.22% in Pharmaceuticals & Biotech, 18.85% in Healthcare Services, 3.41% in Retailing, 0.70% in Debt, -0.18% in Cash & Others
FAQs
How to Invest in Nippon India Pharma Fund (IDCW) Direct Growth?
Nippon India Pharma Fund (IDCW) is a popular fund in the Sectoral / Thematic segment. The fund has generated a return of 20.46% since inception. Looking to invest in Nippon India Pharma Fund (IDCW) How about earning 1% extra return? All this is possible with m.Stock! Investing in Nippon India Pharma Fund (IDCW) is super easy and convenient with m.Stock. Here’s how you can begin:
- Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage on Mutual Funds, Delivery & IPO.
- In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
- In the search bar, enter the fund name, in this case, Nippon India Pharma Fund (IDCW)
- On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
- If you choose to invest a Lumpsum: Use the Lumpsum Calculator to estimate returns, then enter the investment amount, select the payment mode mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
- If you choose the SIP route: Utilize the SIP Calculator to forecast potential growth, then enter the SIP amount, SIP date, and set up ‘Autopay’ facility.
So, why wait? Invest in Nippon India Pharma Fund (IDCW) today and reap the benefits of this Sectoral / Thematic fund!
How much returns has Nippon India Pharma Fund (IDCW) Direct Growth generated?
What is the expense ratio of Nippon India Pharma Fund (IDCW) Direct Growth?
What is the AUM of Nippon India Pharma Fund (IDCW) Fund Direct Growth?
How to redeem or withdraw money from Nippon India Pharma Fund (IDCW) Direct Growth?
Redeeming or selling units of Nippon India Pharma Fund (IDCW) is relatively simple. But before you redeem, ensure that the fund has completed the minimum lock-in period else you will be charged an exit load.
To redeem from Nippon India Pharma Fund (IDCW):
- Login to your m.Stock account
- In portfolio, your mutual fund investments will be visible under ‘MF’
- Select the fund you wish to redeem from (in this case Nippon India Pharma Fund (IDCW)).
- Click on ‘Redeem’ button
- You have 2 options – redeem by units and redeem by value (you can only redeem free units)
- Select units to be redeemed and click on submit.
- Redemption value will be credited to your account in 2-3 working days (as per timelines set by SEBI).